Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Tofacitinib for Biologic-Experienced Hospitalized Patients With Acute Severe Ulcerative Colitis: A Retrospective Case-Control Study.
Berinstein JA, Sheehan JL, Dias M, Berinstein EM, Steiner CA, Johnson LA, Regal RE, Allen JI, Cushing KC, Stidham RW, Bishu S, Kinnucan JAR, Cohen-Mekelburg SA, Waljee AK, Higgins PDR. Berinstein JA, et al. Among authors: sheehan jl. Clin Gastroenterol Hepatol. 2021 Oct;19(10):2112-2120.e1. doi: 10.1016/j.cgh.2021.05.038. Epub 2021 May 25. Clin Gastroenterol Hepatol. 2021. PMID: 34048936 Free PMC article.
Efficacy and Safety of Dual Targeted Therapy for Partially or Non-responsive Inflammatory Bowel Disease: A Systematic Review of the Literature.
Berinstein EM, Sheehan JL, Jacob J, Steiner CA, Stidham RW, Shannon C, Bishu S, Levine J, Cohen-Mekelburg SA, Waljee AK, Higgins PDR, Berinstein JA. Berinstein EM, et al. Among authors: sheehan jl. Dig Dis Sci. 2023 Jun;68(6):2604-2623. doi: 10.1007/s10620-023-07837-0. Epub 2023 Feb 20. Dig Dis Sci. 2023. PMID: 36807832 Free PMC article.
Social Network Diversity and the Daily Burden of Inflammatory Bowel Disease.
Greene-Higgs L, Jordan A, Sheehan J, Berinstein J, Admon AJ, Waljee AK, Riehl M, Piette J, Resnicow K, Higgins PD, Cohen-Mekelburg S. Greene-Higgs L, et al. Clin Transl Gastroenterol. 2023 May 1;14(5):e00572. doi: 10.14309/ctg.0000000000000572. Clin Transl Gastroenterol. 2023. PMID: 36854057 Free PMC article.
Self-Efficacy and the Impact of Inflammatory Bowel Disease on Patients' Daily Lives.
Sheehan JL, Greene-Higgs L, Swanson L, Higgins PDR, Krein SL, Waljee AK, Saini SD, Berinstein JA, Mellinger JL, Piette JD, Resnicow K, Cohen-Mekelburg S. Sheehan JL, et al. Clin Transl Gastroenterol. 2023 Jun 1;14(6):e00577. doi: 10.14309/ctg.0000000000000577. Clin Transl Gastroenterol. 2023. PMID: 36881812 Free PMC article.
Correction to: Efficacy and Safety of Dual Targeted Therapy for Partially or Non‑responsive Inflammatory Bowel Disease: A Systematic Review of the Literature.
Berinstein EM, Sheehan JL, Jacob J, Steiner CA, Stidham RW, Shannon C, Bishu S, Levine J, Cohen-Mekelburg SA, Waljee AK, Higgins PDR, Berinstein JA. Berinstein EM, et al. Among authors: sheehan jl. Dig Dis Sci. 2023 Dec;68(12):4540. doi: 10.1007/s10620-023-08130-w. Dig Dis Sci. 2023. PMID: 37891442 Free PMC article. No abstract available.
Effectiveness of Upadacitinib for Patients With Acute Severe Ulcerative Colitis: A Multicenter Experience.
Berinstein JA, Karl T, Patel A, Dolinger M, Barrett TA, Ahmed W, Click B, Steiner CA, Dulaney D, Levine J, Hassan SA, Perry C, Flomenhoft D, Ungaro RC, Berinstein EM, Sheehan J, Cohen-Mekelburg S, Regal RE, Stidham RW, Bishu S, Colombel JF, Higgins PDR. Berinstein JA, et al. Am J Gastroenterol. 2024 Mar 27. doi: 10.14309/ajg.0000000000002674. Online ahead of print. Am J Gastroenterol. 2024. PMID: 38275248
16 results